Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
First Crystal Structure of a Presenilin
20 December 2012. In this week’s Nature, researchers report the first successful crystal structure of a bacterial presenilin homologue. The human presenilin forms the active part of the transmembrane γ-secretase complex that releases Aβ from its precursor, but it has resisted previous attempts at crystallization and detailed structural study. The authors, led by Yigong Shi at Tsinghua University, Beijing, China, got around that problem by instead using a closely related archaebacterial presenilin/SPP homologue (PSH). Their structural findings largely agree with previous electron microscopy studies of γ-secretase (see ARF related news story and ARF news story). They include more detail and also contain a few surprises, noted Michael Wolfe at Brigham and Women’s Hospital, Boston, Massachusetts, in an accompanying Nature commentary. The biggest surprise is that a small pore pierces through the entire transmembrane region of the protein, raising the question of whether ions or water could pass through the complex.

Christian Haass at Ludwig-Maximilians University, Munich, Germany, wrote to Alzforum that the work represents a “…fantastic breakthrough. I am extremely pleased that many of the seminal findings on structure/function relationships made by numerous researchers in the field were fully confirmed.” (See full comment below.)

The crystal structure confirms that presenilin has nine transmembrane domains (TMDs). Two aspartate residues critical for enzymatic cleavage lie in TMD6 and 7, inside the cell membrane but facing a cytoplasmic pocket that would give them access to water. This is crucial because presenilin needs water to hydrolyze its substrates. Also consistent with previous work (see Kornilova et al., 2005; Sato et al., 2008), the data suggest that substrates slide into presenilin through an open space between TMD6 and TMD9, which exposes them to the active site and its watery cavity. The unexpected finding was the presence of a membrane-spanning hole nestled between TMD2, 3, 5, and 7 (see image below). This pore could provide an additional way for water to reach the active site, or for ions to pass through the protein, Wolfe suggested in his commentary. Some researchers have proposed that presenilin acts as a calcium channel (see ARF related news story). Alternatively, the hole might be plugged by lipids or other small molecules in vivo, the authors note.

Model of PSH shows watery cavity at the active site and a transmembrane pore. Image courtesy of Yigong Shi and Nature

“[The authors’] work opens up a whole new horizon that should ultimately lead to a detailed understanding of human presenilins and of the entire γ-secretase complex. Such understanding should lead to specific ideas about how disease-causing mutations alter function, and how small molecules might be designed for safe and effective treatment of Alzheimer’s disease,” Wolfe wrote.––Madolyn Bowman Rogers.

References:
Li X, Dang S, Yan C, Gong X, Wang J, Shi Y. Structure of a presenilin family intramembrane aspartate protease. Nature. 2012 Dec 19. Abstract

Wolfe M. Membrane enzyme cuts a fine figure. Nature. 2012 Dec 19. Abstract

 
Comments on News and Primary Papers
  Comment by:  Huilin Li
Submitted 20 December 2012  |  Permalink Posted 20 December 2012

This is a very important and extremely interesting work. I am glad to see the 8-angstrom-deep water-accessible cavity near the cytosolic side of the membrane. We saw this in our cryo-EM structure in 2008. We suspected, but didn't have evidence at that time, that this is where the active site is. The transmembrane pore is mysterious. It is hydrophobic, so water or ions are unlikely to pass through.

This pore could be plugged in vivo either by lipid or other partner proteins. Alternatively, the pore may function/facilitate in accommodating single transmembrane helical substrates.

View all comments by Huilin Li


  Comment by:  Christian Haass
Submitted 20 December 2012  |  Permalink Posted 20 December 2012

This is certainly an absolutely fantastic breakthrough. For the very first time, we can see structural details of presenilin! Moreover, I am extremely pleased that many of the seminal findings on structure/function relationships made by numerous researchers in the field were fully confirmed. I find it very interesting that Li et al. crystallized an apparently inactive protease. Maybe that explains what we and others observed upon pull-down of γ-secretase with biotinylated inhibitors.

Apparently, we can capture only a minority of γ-secretase, whereas a large portion remains (inactive?) in the supernatant. Obviously, such great findings immediately ask for more details: I would, for example, love to see a co-crystal with a γ-secretase inhibitor or a γ-secretase substrate. Finally, I think PSH is more an SPP/SPPL-like protease. To prove that, the membrane orientation should be determined.

But these are just additional questions, which now, based on the pioneering work of Li et al., can be addressed.

View all comments by Christian Haass


  Comment by:  Lucia Chavez-Gutierrez, Bart De Strooper, ARF Advisor, Nadav Elad
Submitted 20 December 2012  |  Permalink Posted 20 December 2012

The crystal structure of an archaea homologue of presenilin (mmPSH), just published in Nature, represents a substantial advance in the structural field of membrane proteins that could shed light on the structural basis of the active site of the γ-secretase complex.

The authors carried out a tremendous amount of work to identify well-expressing and stable presenilin homologues that enhance crystallizability. In fact, the report illustrates the enormous efforts and creativity needed to achieve such structural investigation.

Importantly, the crystal structure is consistent with the 9 transmembrane domain (TMD) organization proposed for presenilin, and confirms that the catalytic site is located in a cavity connected to the cytoplasmic side, illustrating how water molecules reach the catalytic aspartates. However, the mmPSH structure seems to represent an inactive state of the protease, in which the catalytic aspartates are uncoupled, indicating that structural adjustments should occur in order to bring it into the active conformation. Interestingly, this observation is...  Read more


  Comment by:  Taisuke Tomita
Submitted 21 December 2012  |  Permalink Posted 21 December 2012

By Taisuke Tomita and Takeshi Iwatsubo
Li and colleagues have provided the first crystal structure of an archaeal presenilin protein. As the authors mentioned, despite extensive years of efforts on eukaryotic presenilins, the crystal structure of PS has not been elucidated. The findings of Li et al. are significant in that they obtained crystals of “proteolytically active” forms of presenilin/SPP homologue (PSH) that are suitable for X-ray diffraction analysis, by testing a series of mutants as well as adopting protease digestion. Taken together with the previous structural data on rhomboid and S2P, this new PSH structure strongly supports the notion that “intra”membrane cleavage is a general proteolytic reaction occurring in the hydrophilic environment within the lipid bilayer.

The structure exhibits several intriguing features: Notably, the catalytic module of PSH is formed by transmembrane domains (TMD) 6-9, and TMD9 is likely to serve as a gate for substrate entry. This dovetails quite well with the predicted structural features based on cysteine scanning...  Read more


  Comment by:  Ilya Bezprozvanny
Submitted 26 December 2012  |  Permalink Posted 26 December 2012

The paper by Li et al. is a real tour de force that offers the first atomic resolution information about the three-dimensional structure of presenilins. Multiple laboratories around the world attempted to crystallize presenilins previously but have not been successful. The group headed by Yigong Shi achieved this difficult goal by focusing on an archaeal homologue called PSH, generating a series of PSH point mutants to achieve diffraction-quality crystals. As a result of this tremendous effort, the authors determined the structure of PSH at 3.3 angstrom resolution, sufficient to see most critical aspects of its conformation.

They determined that PSH is composed of nine transmembrane domains (TMDs), consistent with most recent biochemical structure-function analyses. The topology of PSH differs from two previously crystallized intramembrane proteases—rhomboid and S2 protease. The resolution of the structure is sufficiently high to visualize a large, water-filled hole that traverses the entire protein across the lipid bilayer. The hole is surrounded by TMD2, TMD3, TMD5, and...  Read more


  Comment by:  Miguel Rodríguez-Manotas
Submitted 21 December 2012  |  Permalink Posted 26 December 2012

The existence of such a hole was previously envisioned in our article, where we explained the hypothetical role of such a pore.

References:
Rodríguez-Manotas M, Amorín-Díaz M, Cabezas-Herrera J, Acedo-Martínez A, Llorca-Escuín I. Are γ-secretase and its associated Alzheimer's disease γ problems? Med Hypotheses. 2012 Feb;78(2):299-304. Abstract

View all comments by Miguel Rodríguez-Manotas
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad